Psoriatic arthritis can affect people differently, but the most common symptoms include: These symptoms can range from mild to severe, with unpredictable flare-ups. Wellness No need to let winter ...

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Methotrexate (MTX) is a drug that has been used to treat psoriatic arthritis (PsA ... anti-inflammatory and can be useful on its own for mild cases of PsA. A clinical trial published in 2018 ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Psoriatic arthritis can affect any joint in your body, causing mild to severe symptoms that are packed with pain and stiffness. More severe psoriatic arthritis flares make it hard or impossible to ...

Are you searching for effective medications to treat 'Psoriatic Arthritis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related radiographic damage to the axial or peripheral joints, new study reveals.

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It is more prevalent in Europe and North America than in Asia and South ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...